Clinical trial / 2019
TMAO and its precursors were elevated in PCOS and decreased after 3 months of oral contraceptive use paired with general dietary advice.
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
- Study type
- Prospective intervention study with a matched control group
- Who was studied
- 27 overweight/obese patients with PCOS and 25 age- and BMI-matched healthy control women
- What was measured
- Circulating TMAO and its precursors (choline, betaine, carnitine)
THE PAPER
Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, Uyanik E, Bjørndal B, Berge RK, Svardal A, Yildiz BO. Clin Endocrinol (Oxf), 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.